Additionally, the agency has received adverse event reports that may be related to patients prescribed compounded semaglutide or tirzepatide products in doses beyond what is in the FDA-approved drug label
Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, et al
It is best to combine medication with lifestyle changes if your goal is to lose excess weight and keep it off
Look at the weekly trend line, not any single reading
doi: 10.3389/fendo.2025.1586589 Received 03 March 2025 Accepted 29 April 2025 Published 21 May 2025 Volume 16 - 2025 Edited by Giacomina Brunetti, University of Bari Aldo Moro, Italy Reviewed by Nagesha Guthalu Kondegowda, City of Hope, United States Nikita Nirwan, Jamia Hamdard University, India Updates Copyright 2025 Chen, Lyu, Zhao, Han, Huang, Yang and Zhou